REPORTS

Let’s Pullulate and Expand Your Business

Global Gastrointestinal Therapeutics and Diagnostics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 11, 2020  |  209 PAGES  |  REPORT CODE: CMM346400
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.

The Gastrointestinal Therapeutics and Diagnostics is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period. The research provides insights for the global Gastrointestinal Therapeutics and Diagnostics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Gastrointestinal Therapeutics and Diagnostics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Gastrointestinal Therapeutics and Diagnostics Market Segmentations:

By Players:

  • Abbott Laboratories

  • Allergan

  • AstraZeneca

  • Bayer AG

  • GlaxoSmithKline

  • Janssen Pharmaceuticals

  • Takeda Pharmaceutical

  • Valeant Pharmaceuticals

  • Pfizer

  • AbbVie, Inc

By Types:

  • Diagnostics

  • Therapeutics

By End-User:

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastrointestinal Therapeutics and Diagnostics Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Diagnostics from 2014 to 2026

    • 1.3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Therapeutics from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • 1.4.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • 1.4.3 Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Gastrointestinal Therapeutics and Diagnostics Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Gastrointestinal Therapeutics and Diagnostics by Major Types

    • 3.4.1 Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Diagnostics

    • 3.4.2 Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Therapeutics

4 Segmentation of Gastrointestinal Therapeutics and Diagnostics Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Gastrointestinal Therapeutics and Diagnostics by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Gastrointestinal Therapeutics and Diagnostics in Hospital Pharmacies

    • 4.4.2 Market Size and Growth Rate of Gastrointestinal Therapeutics and Diagnostics in Retail Pharmacies

    • 4.4.3 Market Size and Growth Rate of Gastrointestinal Therapeutics and Diagnostics in Online Pharmacies

5 Market Analysis by Major Regions

  • 5.1 Global Gastrointestinal Therapeutics and Diagnostics Production Analysis by Major Regions

  • 5.2 Global Gastrointestinal Therapeutics and Diagnostics Consumption Analysis by Major Regions

  • 5.3 Global Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

6 Product Commodity of Gastrointestinal Therapeutics and Diagnostics Market in Major Countries

  • 6.1 Top 5 Export Countries in Gastrointestinal Therapeutics and Diagnostics market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Gastrointestinal Therapeutics and Diagnostics market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Gastrointestinal Therapeutics and Diagnostics market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Gastrointestinal Therapeutics and Diagnostics market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Gastrointestinal Therapeutics and Diagnostics market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Gastrointestinal Therapeutics and Diagnostics market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Gastrointestinal Therapeutics and Diagnostics Landscape Analysis

  • 7.1 North America Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major Types

  • 7.2 North America Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major End-Users

  • 7.3 North America Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major Countries

    • 7.3.1 United States Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 7.3.2 Canada Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 7.3.3 Mexico Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

8 Europe Gastrointestinal Therapeutics and Diagnostics Landscape Analysis

  • 8.1 Europe Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major Types

  • 8.2 Europe Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major End-Users

  • 8.3 Europe Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major Countries

    • 8.3.1 Germany Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.2 UK Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.3 France Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.4 Italy Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.6 Spain Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.7 Belgium Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.8 Poland Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.9 Russia Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.10 Turkey Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

9 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Landscape Analysis

  • 9.1 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major Types

  • 9.2 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major Countries

    • 9.3.1 China Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 9.3.2 Japan Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 9.3.4 India Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 9.3.6 South Korea Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

10 Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 10.3.2 Brazil Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 10.3.3 Nigeria Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

    • 10.3.4 South Africa Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate 

    • 10.3.5 Argentina Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Abbott Laboratories

    • 11.1.1 Abbott Laboratories Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Allergan

    • 11.2.1 Allergan Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 AstraZeneca

    • 11.3.1 AstraZeneca Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Bayer AG

    • 11.4.1 Bayer AG Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 GlaxoSmithKline

    • 11.5.1 GlaxoSmithKline Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Janssen Pharmaceuticals

    • 11.6.1 Janssen Pharmaceuticals Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Takeda Pharmaceutical

    • 11.7.1 Takeda Pharmaceutical Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Valeant Pharmaceuticals

    • 11.8.1 Valeant Pharmaceuticals Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Pfizer

    • 11.9.1 Pfizer Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 AbbVie, Inc

    • 11.10.1 AbbVie, Inc Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 76 Figures and 134 Tables)

  • Figure Product Picture

  • Figure Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Diagnostics from 2014 to 2026

  • Figure Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Therapeutics from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

  • Figure Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

  • Figure Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Gastrointestinal Therapeutics and Diagnostics Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Gastrointestinal Therapeutics and Diagnostics

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Gastrointestinal Therapeutics and Diagnostics by Different Types from 2014 to 2026

  • Table Consumption Share of Gastrointestinal Therapeutics and Diagnostics by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Diagnostics

  • Figure Market Size and Growth Rate of Therapeutics

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Gastrointestinal Therapeutics and Diagnostics by Different End-Users from 2014 to 2026

  • Table Consumption Share of Gastrointestinal Therapeutics and Diagnostics by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Hospital Pharmacies

  • Figure Market Size and Growth Rate of Retail Pharmacies

  • Figure Market Size and Growth Rate of Online Pharmacies

  • Table Global Gastrointestinal Therapeutics and Diagnostics Production by Major Regions

  • Table Global Gastrointestinal Therapeutics and Diagnostics Production Share by Major Regions

  • Figure Global Gastrointestinal Therapeutics and Diagnostics Production Share by Major Regions in 2014

  • Figure Global Gastrointestinal Therapeutics and Diagnostics Production Share by Major Regions in 2018

  • Figure Global Gastrointestinal Therapeutics and Diagnostics Production Share by Major Regions in 2026

  • Table Global Gastrointestinal Therapeutics and Diagnostics Consumption by Major Regions

  • Table Global Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Regions

  • Figure Global Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Regions in 2014

  • Figure Global Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Regions in 2018

  • Figure Global Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Regions in 2026

  • Table North America Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

  • Table Europe Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Gastrointestinal Therapeutics and Diagnostics market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Gastrointestinal Therapeutics and Diagnostics market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Gastrointestinal Therapeutics and Diagnostics market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Gastrointestinal Therapeutics and Diagnostics market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Gastrointestinal Therapeutics and Diagnostics Consumption by Types from 2014 to 2026

  • Table North America Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types from 2014 to 2026

  • Figure North America Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2014

  • Figure North America Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2018

  • Figure North America Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2026

  • Table North America Gastrointestinal Therapeutics and Diagnostics Consumption by End-Users from 2014 to 2026

  • Table North America Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users from 2014 to 2026

  • Figure North America Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2014

  • Figure North America Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2018

  • Figure North America Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2026

  • Table North America Gastrointestinal Therapeutics and Diagnostics Consumption by Major Countries from 2014 to 2026

  • Table North America Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries in 2014

  • Figure North America Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries in 2018

  • Figure North America Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries in 2026

  • Figure United States Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Gastrointestinal Therapeutics and Diagnostics Consumption by Types from 2014 to 2026

  • Table Europe Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types from 2014 to 2026

  • Figure Europe Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2014

  • Figure Europe Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2018

  • Figure Europe Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2026

  • Table Europe Gastrointestinal Therapeutics and Diagnostics Consumption by End-Users from 2014 to 2026

  • Table Europe Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2014

  • Figure Europe Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2018

  • Figure Europe Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2026

  • Table Europe Gastrointestinal Therapeutics and Diagnostics Consumption by Major Countries from 2014 to 2026

  • Table Europe Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries in 2014

  • Figure Europe Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries in 2018

  • Figure Europe Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries in 2026

  • Figure Germany Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure France Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption by Types from 2014 to 2026

  • Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2014

  • Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2018

  • Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2026

  • Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2014

  • Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2018

  • Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2026

  • Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries in 2026

  • Figure China Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandGastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure India Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Consumption Share by Major Countries in 2026

  • Figure GCC Countries Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Gastrointestinal Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Abbott Laboratories

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

  • Figure Sales and Growth Rate Analysis of Abbott Laboratories

  • Figure Revenue and Market Share Analysis of Abbott Laboratories

  • Table Product and Service Introduction of Abbott Laboratories

  • Table Company Profile and Development Status of Allergan

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

  • Figure Sales and Growth Rate Analysis of Allergan

  • Figure Revenue and Market Share Analysis of Allergan

  • Table Product and Service Introduction of Allergan

  • Table Company Profile and Development Status of AstraZeneca

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

  • Figure Sales and Growth Rate Analysis of AstraZeneca

  • Figure Revenue and Market Share Analysis of AstraZeneca

  • Table Product and Service Introduction of AstraZeneca

  • Table Company Profile and Development Status of Bayer AG

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

  • Figure Sales and Growth Rate Analysis of Bayer AG

  • Figure Revenue and Market Share Analysis of Bayer AG

  • Table Product and Service Introduction of Bayer AG

  • Table Company Profile and Development Status of GlaxoSmithKline

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline

  • Table Product and Service Introduction of GlaxoSmithKline

  • Table Company Profile and Development Status of Janssen Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals

  • Table Product and Service Introduction of Janssen Pharmaceuticals

  • Table Company Profile and Development Status of Takeda Pharmaceutical

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical

  • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical

  • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical

  • Table Product and Service Introduction of Takeda Pharmaceutical

  • Table Company Profile and Development Status of Valeant Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals

  • Table Product and Service Introduction of Valeant Pharmaceuticals

  • Table Company Profile and Development Status of Pfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

  • Figure Sales and Growth Rate Analysis of Pfizer

  • Figure Revenue and Market Share Analysis of Pfizer

  • Table Product and Service Introduction of Pfizer

  • Table Company Profile and Development Status of AbbVie, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie, Inc

  • Figure Sales and Growth Rate Analysis of AbbVie, Inc

  • Figure Revenue and Market Share Analysis of AbbVie, Inc

  • Table Product and Service Introduction of AbbVie, Inc


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top